Canadian Drug Regulators Unveil Fee Increases

International Pharmaceutical Regulatory Monitor
A A
Health Canada proposed fee hikes for reviewing new drug applications, oversight of manufacturing facilities, postmarket monitoring of sales and other regulatory activities.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor